Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in <scp>CLL</scp>-Reference-Cited by-同舟云学术

Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL

Published:2022-08 Issue:8 Volume:18 Page:
ISSN:1744-4292
Container-title:Molecular Systems Biology
language:en
Short-container-title:Molecular Systems Biology

Author:

Bruch Peter‐Martin¹²^ORCID,Giles Holly AR¹²³⁴^ORCID,Kolb Carolin¹²,Herbst Sophie A¹²³⁵^ORCID,Becirovic Tina¹,Roider Tobias¹²³^ORCID,Lu Junyan³,Scheinost Sebastian⁵⁶,Wagner Lena⁵⁶,Huellein Jennifer³,Berest Ivan³,Kriegsmann Mark⁷,Kriegsmann Katharina¹,Zgorzelski Christiane⁷,Dreger Peter¹,Zaugg Judith B²³^ORCID,Müller‐Tidow Carsten¹²,Zenz Thorsten⁸^ORCID,Huber Wolfgang²³^ORCID,Dietrich Sascha¹²³⁵^ORCID

Affiliation:

1. Department of Medicine V Heidelberg University Hospital Heidelberg Germany

2. Molecular Medicine Partnership Unit (MMPU) Heidelberg Germany

3. EMBL Heidelberg Heidelberg Germany

4. Collaboration for Joint PhD Degree between EMBL and Heidelberg University Faculty of Biosciences Heidelberg Germany

5. German Cancer Research Center (DKFZ) Heidelberg Germany

6. National Center for Tumour Diseases Heidelberg Germany

7. Institute of Pathology University of Heidelberg Heidelberg Germany

8. Department of Hematology University of Zürich Zürich Switzerland

Funder

Bundesministerium für Bildung und Forschung

Deutsche Forschungsgemeinschaft

Publisher

EMBO

Subject

Applied Mathematics,Computational Theory and Mathematics,General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,Information Systems

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/msb.202110855

Reference56 articles.

1. IL-4 enhances expression and function of surface IgM in CLL cells

2. Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study

3. genomation: a toolkit to summarize, annotate and visualize genomic intervals

4. QuPath: Open source software for digital pathology image analysis

5. Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel meriolin derivatives potently inhibit cell cycle progression and transcription in leukemia and lymphoma cells via inhibition of cyclin- dependent kinases (CDKs);2024-01-25

2. Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial;Nature Cancer;2023-10-02

3. Comparing the value of mono- vs coculture for high-throughput compound screening in hematological malignancies;Blood Advances;2023-09-29

4. Dimethyl itaconate selectively targets inflammatory and metabolic pathways in chronic lymphocytic leukemia;European Journal of Immunology;2023-09-04

5. Recent revelations and future directions using single-cell technologies in chronic lymphocytic leukemia;Frontiers in Oncology;2023-04-06